Safety and effectiveness of a new ophthalmic viscosurgical device: randomized, controlled study.

ABSTRACT:

Purpose

To evaluate the safety and effectiveness of a new dispersive ophthalmic viscosurgical device (OVD) (ClearVisc) compared with an approved dispersive OVD (Viscoat) when used in cataract surgery.

Setting

16 clinics in the United States.

Design

Prospective multicenter controlled randomized 1:1 (ClearVisc:Viscoat; stratified by site, age group, and cataract severity). Patients and examiners masked.

Methods

Patients aged 45 years or older with age-related noncomplicated cataract considered amenable to treatment with standard phacoemulsification cataract extraction and intraocular lens (IOL) implantation were included. Patients were randomized to receive either ClearVisc or Viscoat using standard techniques. 5 postoperative visits occurred at 6 hours, 24 hours

SUBMITTER: Packer M 

PROVIDER: S-EPMC9415196 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature